Stock Expert AI

LGHT (LGHT) ETF Analysis

LGHT is an ETF focused on the healthcare technology sector, offering targeted exposure to companies involved in medical devices, healthcare IT, and related technological advancements. With a concentrated portfolio of 10 holdings, LGHT provides a focused approach to investing in healthcare innovation. The fund's top holdings include Intuitive Surgical Inc (14.99%) and ResMed Inc (10.58%). LGHT presents a specialized investment vehicle for those seeking to capitalize on the growth potential within the healthcare technology space.

LGHT (LGHT) ETF — Price, Holdings & Analysis

LGHT is an ETF focused on the healthcare technology sector, offering targeted exposure to companies involved in medical devices, healthcare IT, and related technological advancements. With a concentrated portfolio of 10 holdings, LGHT provides a focused approach to investing in healthcare innovation. The fund's top holdings include Intuitive Surgical Inc (14.99%) and ResMed Inc (10.58%). LGHT presents a specialized investment vehicle for those seeking to capitalize on the growth potential within the healthcare technology space.

ETF Overview

LGHT aims to provide investors with exposure to companies at the forefront of healthcare technology. The ETF achieves this by investing in a concentrated portfolio of approximately 10 companies that are leaders and innovators in the healthcare technology industry. This focused approach allows investors to target specific areas of growth within the broader healthcare sector, such as medical devices, healthcare IT solutions, and advanced diagnostics. The ETF's top holdings, including Intuitive Surgical Inc (14.99%), ResMed Inc (10.58%), and GE HealthCare Technologies Inc Common Stock (9.74%), reflect its emphasis on established companies with significant market presence and innovative technologies. By concentrating its investments in a select group of companies, LGHT offers a differentiated approach compared to broader healthcare ETFs that may include pharmaceutical companies or healthcare service providers. This targeted strategy may appeal to investors seeking to capitalize on the specific growth drivers within the healthcare technology sub-sector. Past performance does not guarantee future results.

Risk Metrics

LGHT's concentrated portfolio of 10 holdings introduces a higher level of concentration risk compared to more diversified ETFs. The fund's top holding, Intuitive Surgical Inc, accounts for 14.99% of the portfolio, meaning that the ETF's performance is significantly influenced by the performance of this single company. Similarly, the top 3 holdings constitute over 35% of the fund. The fund's focus on healthcare technology also exposes it to sector-specific risks, such as regulatory changes, technological obsolescence, and competitive pressures within the healthcare industry. With a beta of 0.00, LGHT has demonstrated very low volatility relative to the broader market. The expense ratio will also create a drag on performance over time, reducing overall returns. Investors should carefully consider their risk tolerance and investment objectives before investing in LGHT. Past performance does not guarantee future results.

Top Holdings

Dividend Yield

0.00%

Risk Metrics

  • Beta: 0.00

Questions & Answers

What is LGHT and what does it track?

LGHT is an exchange-traded fund (ETF) that focuses on providing investors with targeted exposure to the healthcare technology sector. The ETF invests in a concentrated portfolio of approximately 10 companies that are leaders and innovators in the healthcare technology industry. This includes companies involved in medical devices, healthcare IT solutions, and advanced diagnostics. By focusing on a select group of companies, LGHT aims to capture the growth potential within this specific sub-sector of the healthcare market. The fund's holdings are weighted to reflect the relative importance and impact of these companies within the healthcare technology landscape.

What is the expense ratio for LGHT?

While the expense ratio for LGHT is not explicitly provided in the given data, it's a crucial factor to consider when evaluating the ETF's overall cost. The expense ratio represents the annual fee charged by the fund to cover its operating expenses. This fee is deducted from the fund's assets and can impact its overall performance. When considering LGHT, investors should compare its expense ratio to the average expense ratio of similar ETFs in the healthcare or technology sectors to assess its cost-competitiveness.

What are the top holdings in LGHT?

LGHT's portfolio is concentrated in a small number of holdings. As of 2026-03-15, the top holdings include Intuitive Surgical Inc (ISRG) at 14.99%, ResMed Inc (RMD) at 10.58%, and GE HealthCare Technologies Inc Common Stock (GEHC) at 9.74%. These companies represent a significant portion of the fund's assets, reflecting LGHT's strategy of focusing on key players in the healthcare technology sector. Other notable holdings include Insulet Corp (PODD) at 7.01% and Veeva Systems Inc Class A (VEEV) at 6.87%.

Is LGHT a good long-term investment?

Evaluating whether LGHT is a suitable long-term investment requires careful consideration of its investment strategy, risk profile, and market context. LGHT's concentrated portfolio and focus on the healthcare technology sector offer the potential for high growth, but also introduce concentration risk and sector-specific risks. The fund's beta of 0.00 suggests low volatility relative to the broader market, but past performance does not guarantee future results. Investors should assess their own risk tolerance and investment objectives before deciding whether LGHT aligns with their long-term investment goals.

How does LGHT compare to similar ETFs?

Without specific data on competitor ETFs, a direct comparison is challenging. However, LGHT's defining characteristic is its concentrated portfolio of 10 holdings, offering a focused approach to healthcare technology. Other ETFs in the healthcare or technology space may have a larger number of holdings, providing broader diversification but potentially diluting exposure to specific growth opportunities. Investors should compare LGHT's expense ratio, investment strategy, and historical performance to those of similar ETFs to determine which fund best aligns with their investment goals.

Does LGHT pay dividends?

Based on the provided data, LGHT has a dividend yield of 0.00%. This indicates that the ETF does not currently distribute dividends to its shareholders. Investors seeking income-generating investments may want to consider other ETFs with a higher dividend yield. However, LGHT's focus on growth-oriented companies in the healthcare technology sector may prioritize capital appreciation over dividend payments.